Issue Information

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
by: Bernadette A. Fausto, et al.
Published: (2026)

Alzheimer's disease drug development pipeline: 2026
by: Jeffrey L. Cummings, et al.
Published: (2026)

Infusion‐related reactions in donanemab‐treated participants with early symptomatic Alzheimer's disease
by: Paul Ardayfio, et al.
Published: (2026)

Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
by: David Lukacsovich, et al.
Published: (2026)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
by: Mai Othman, et al.
Published: (2026)

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach
by: Jamie C. Fong, et al.
Published: (2026)

A sex‐specific “hormone–bone–brain” axis in Alzheimer's disease: Integrating Global Burden of Disease data and Mendelian randomization analysis to reveal the causal role of osteocalcin
by: Zhiyang Zheng, et al.
Published: (2026)

Biomarkers in Alzheimer's disease clinical trials: 2025
by: Amanda M. Leisgang Osse, et al.
Published: (2026)

Association of Excessive Daytime Sleepiness With Long‐Term Incident Dementia: The Role of β‐Amyloid and White Matter Injury
by: Xiaowen Zhou, et al.
Published: (2026)

Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
by: Anaëlle Bain, et al.
Published: (2026)

Brain networks modulating the relationship between white matter volume and cognition
by: Osamu Katayama, et al.
Published: (2026)

Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation
by: Maansi Barnwal, et al.
Published: (2026)

From companionship to science: the importance of dogs in advancing translational research on Alzheimer's disease – a scoping review
by: Heloísa Máximo Ribeiro, et al.
Published: (2026)

Weight loss and metabolic improvements dominate the microbiome response in the MIND diet intervention: a randomized controlled trial
by: Robin M. Voigt, et al.
Published: (2026)

The momentum for dementia research in Brazil
by: Mychael V. Lourenco
Published: (2026)

Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials
by: Susanna Gobbi, et al.
Published: (2026)

Cognitive training, alone and combined with acetylcholinesterase inhibitors, in neurocognitive disorders: long‐term efficacy and the role of cognitive reserve on 30 months of intervention
by: Adele Ravelli, et al.
Published: (2026)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
by: Zhigang Xie, et al.
Published: (2026)

Decentralizing dementia research to the US–Mexico border: the Rio Grande Valley AD‐RCMAR as a model for translational equity
by: Gladys E. Maestre, et al.
Published: (2026)

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study
by: Davide Angioni, et al.
Published: (2026)

Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline
by: Emilija Romic, et al.
Published: (2026)

Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four‐arm, cluster randomized trial
by: Zhaoxue Yin, et al.
Published: (2026)

Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
by: Norma B. Coe, et al.
Published: (2026)

Mapping brain change longitudinally: physical activity intervention reshapes structural alterations and functional connectivity in Alzheimer's disease
by: Ravi Dadsena, et al.
Published: (2026)

The I‐Learn Cognition and Behavior program for non‐pharmacological treatment of agitation in nursing home residents with neurocognitive disorders: A cluster randomized trial
by: Céline Lourdel, et al.
Published: (2026)

Alzheimer's disease Stage 1 and 2: Biology, diagnostics, and treatment
by: Suzanne E. Schindler, et al.
Published: (2026)

Differential relationships between cardiorespiratory fitness and cortical thickness across the adult lifespan: A generalized additive model approach
by: Jillian H. Graham, et al.
Published: (2026)

Vascular cognitive impairment and dementia drug‐development pipeline 2025
by: Ying Xu, et al.
Published: (2026)

Amyloid: An evolutionarily conserved protein to fight infection or a toxic protein that causes Alzheimer's disease?
by: Jahnavi Shriram, et al.
Published: (2026)

EXPRESSION OF CONCERN: Focused Transcranial Ultrasound for Treatment of Neurodegenerative Dementia
Published: (2026)

Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling
by: Kate E. Foley, et al.
Published: (2026)

Study of the utility and impact of a plasma p‐tau181 Alzheimer's biomarker (SUITABLE)
by: Kyra O'Brien, et al.
Published: (2026)

Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease
by: Yi Shi, et al.
Published: (2026)

Sex differences in blood pressure hemodynamics and white matter hyperintensity volume across racial ethnic groups—HABS‐HD
by: Cellas A. Hayes, et al.
Published: (2026)